Staphylococcus aureus Endocarditis
Vance G. Fowler, José Maria Miró, Bruno Hoen et al. · JAMA · 2005
CONTEXT: The global significance of infective endocarditis (IE) caused by Staphylococcus aureus is unknown. OBJECTIVES: To document the international emergence of health care-associated S aureus IE and methicillin-resistant S aureus (MRSA) IE and to evaluate regional variation in patients with S aureus IE. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study set in 39 medical centers in 16 countries. Participants were a population of 1779 patients with definite IE as defined by Duke criteria who were enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study from June 2000 to December 2003. MAIN OUTCOME MEASURE: In-hospital mortality. RESULTS: S aureus was the most common pathogen among the 1779 cases of definite IE in the International Collaboration on Endocarditis Prospective-Cohort Study (558 patients, 31.4%). Health care-associated infection was the most common form of S aureus IE (218 patients, 39.1%), accounting for 25.9% (Australia/New Zealand) to 54.2% (Brazil) of cases. Most patients with health care-associated S aureus IE (131 patients, 60.1%) acquired the infection outside of the hospital. MRSA IE was more common in the United States (37.2%) and Brazil (37.5%) than in Europe/Middle East (23.7%) and Australia/New Zealand (15.5%, P<.001). Persistent bacteremia was independently associated with MRSA IE (odds ratio, 6.2; 95% confidence interval, 2.9-13.2). Patients in the United States were most likely to be hemodialysis dependent, to have diabetes, to have a presumed intravascular device source, to receive vancomycin, to be infected with MRSA, and to have persistent bacteremia (P<.001 for all comparisons). CONCLUSIONS: S aureus is the leading cause of IE in many regions of the world. Characteristics of patients with S aureus IE vary significantly by region. Further studies are required to determine the causes of regional variation.
Cited by 1,179 works. doi:10.1001/jama.293.24.3012
Authors
- Vance G. Fowler
- José Maria Miró
- Bruno Hoen
- Christopher H. Cabell
- Elías Abrutyn
- Ethan Rubinstein
- G. Ralph Corey
- Denis Spelman
- Suzanne Bradley
- Bruno Baršić
- Paul A. Pappas
- Kevin Joseph Anstrom
- DANNAH W. WRAY
- Cláudio Querido Fortes
- Ignasi Anguera
- Eugene Athan
- Jan T. M. van der Meer
- Tom SJ Elliott
- Donald P. Levine
References
- Longitudinal Data Analysis Using Generalized Linear Models
- The Epidemiology of Sepsis in the United States from 1979 through 2000
- New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings
- Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
- ACC/AHA guidelines for the management of patients with valvular heart disease
- Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus Infection
- Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections
- Treatment of Infections Associated with Surgical Implants
- Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis